ClinicalTrials.gg
RecruitingNCT07125196ISODEPUpdated Feb 9, 2026

Incidence of Depression and Its Complications After Surgical Site Infection - ISODEP.

An interventional study of Data collection and self-administered questionnaire in Surgical Site Infections, Depression and Malnutrition, sponsored by University Hospital, Bordeaux. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-09.

Sponsored by University Hospital, Bordeaux · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Started Dec 2025; still recruiting 11 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 21 studies in Surgical Wound Infection with a site in France — 4 open to participants now, 4 under way, 1 of them phase 3. Surgical Wound Infection · France.

Planned enrollment
7th of 13
300 · median 300
Started
2025
with 1 other
No phase
6 of 21
2 open now
Registered
18th of 21
by date
Lead sponsor
1 of 21
University Hospital, Bordeaux

Among the 21 studies in Surgical Wound Infection with a site in France, this one is the 7th largest by planned enrollment of the 13 interventional ones that give a count, is one of 2 that started in 2025, is one of 6 with no phase, and was the 18th registered.

Surgical Wound Infection

747 studies on the registry are indexed under Surgical Wound Infection; 152 are open to participants now.

Browse Surgical Wound Infection studies →

Open to participants now

4 of the 21 studies in Surgical Wound Infection with a site in France are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 85 Surgical Wound Infection studies recruiting now, 62 (73%) set no upper age limit and 16 (19%) stop at 75 or younger; 12 take children under 18; 14 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 21 studies in Surgical Wound Infection with a site in France, or all of them as a file.
02

Study summary

Surgical-site infection (SSI) in orthopedic surgery is a serious and frequent complication with many consequences on the patient's quality of life. This study aims to describe the incidence of depression and its complications like malnutrition in patients followed for surgical site infection to allow their best management and prevention

Read the detailed description

We will conduct a monocentric (department orthopedic surgery, University Hospital of Bordeaux, France) prospective observational study for 5 years, involving all patients treated for surgical site infection (prosthetic surgery and trauma surgery) The data collected will concern the general condition of the patients, demographic data, information about septic condition, psychiatric disorders, or nutritional conditions, as well as the care provided. A three-year follow-up will be planned

03

Conditions studied

  • Surgical Site Infections
  • Depression
  • Malnutrition

Keywords

  • surgical site infection
  • depression
  • malnutrition
  • orthopedic surgery
  • mood disorders
  • infection management
  • prospective study
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patient >18 years old
  • Patient treated in infectiology for surgical site infection after orthopedic surgery of the limbs or spine:

    • Prosthetic limb surgery
    • Spinal surgery
    • Traumatology: Osteosynthesis of peripheral limbs or spine

Exclusion criteria

Exclusion Criteria:

  • Patient under guardianship or curatorship,
  • Pregnant, breastfeeding woman
  • Person deprived of liberty by judicial or administrative decision,
  • Person undergoing psychiatric treatment under duress requiring the consent of the legal representative.
  • Person unable to express their consent,
  • Person under legal protection,
  • Patient not affiliated to a social protection scheme.
  • Patient with a history of diagnosed depression, hospitalization for depressive disorders or taking mood-regulating treatments.
  • An initial of less than \< 18.5, the existence a cancerous pathology, an ongoing inflammatory disease, a pathology responsible for chronic undernutrition
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
300 participants (estimated)

Study arms

  • Other
    Surgical site infection

    Patients treated for surgical site infection (prosthetic surgery and trauma surgery)

    Other: Data collection and self-administered questionnaire

Interventions

  • OtherData collection and self-administered questionnaire

    Exhaustive collection of data in a health data warehouse: collection of clinical, radiological examinations (standard of care), and self-administered questionnaire: a questionnaire concerning the psychological state of the patients (questionnaire according to DSM V) and a questionnaire on nutritional status.

06

What researchers measure

Primary outcomes

  1. Incidence of Major Depressive Episodes

    Incidence of major depressive episodes as defined by the DSM V criteria, screened using the Major Depression Inventory (MDI) score. This will be assessed at baseline (M0) and at subsequent follow-up visits (Weeks 6, Month 3, Month 6 and Month 12).

    Time frame: Weeks 6, Month 3, Month 6 and Month 12

Secondary outcomes

  1. Socio-Demographic and Clinical Characteristics

    Collection of socio-demographic data including age, sex, employment status, medical and surgical history, and smoking status at baseline and at the end of the study (M12).

    Time frame: Baseline (day 0) and 12 months (M12)

  2. Incidence of Malnutrition and Its Risk Factors

    \- Malnutrition is defined by weight loss ≥ 5% in 1 month, ≥ 10% in 6 months, or ≥ 10% compared to usual weight before illness (HAS definition); BMI \< 18.5 kg/m².

    Time frame: 12 months

  3. Prognostic Significance of Malnutrition and Depression on Infection Treatment Efficacy and Safety

    \- Success of infection treatment defined by the cessation of ongoing antibiotic therapy.

    Time frame: Baseline (Day 0), Week 6, Month 3, Month 6, and Month 12

  4. Incidence of Malnutrition and Its Risk Factors

    Monitoring current nutritional management (oral supplements, nutritional assessments conducted).

    Time frame: 12 months

  5. Incidence of Malnutrition and Its Risk Factors

    \- Biological criteria for malnutrition: levels of albumin, pre-albumin, folate (B9), and vitamin B12.

    Time frame: 12 months

  6. Incidence of Malnutrition and Its Risk Factors

    \- Assessment using the Mini Nutritional Assessment (MNA) questionnaire.

    Time frame: 12 months

  7. Prognostic Significance of Malnutrition and Depression on Infection Treatment Efficacy and Safety

    \- Modifications in infection management due to malnutrition and depression events: treatment discontinuation, therapeutic changes.

    Time frame: Baseline ( Day 0), Week 6, Month 3, Month 6, and Month 12

  8. Prognostic Significance of Malnutrition and Depression on Infection Treatment Efficacy and Safety

    \- Quality of life scales: SF-36 (SF-36v2® Health Survey ©) and EQ-5D-5L (EuroQol Research Foundation©). These parameters will be assessed at baseline (Day 0) and during follow-up visits (W6, M3, M6, and M12).

    Time frame: Baseline (Day0), Week 6, Month 3, Month 6, and Month 12

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2025 (actual). Primary completion is estimated for Sep 2026, 9 months after the start.

Of 202 non-industry interventional studies with no phase under Surgical Wound Infection, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 47. This study's planned 9 months is below that.

Counting every sponsor, half of 209 studies reached it within 24 months; a quarter within 12 and three quarters within 44.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 7, 2025
First posted
Aug 15, 2025
StartActual
Dec 11, 2025
Primary completionEst.
Sep 2026
CompletionEst.
Jul 2029
Last update
Feb 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07125196
Responsible party
Sponsor
First posted
Aug 15, 2025
Start date
Dec 11, 2025
Primary completion
Sep 2026 (estimated)
Completion
Jul 2029 (estimated)
Last update
Feb 9, 2026

Study contacts

Benjamin BOUYER, PROF
Contact
b.bouyer@chu-bordeaux.fr
+335 56 79 87 18
Romain HUGUET
Contact
romain.huguet@chu-bordeaux.fr
Benjamin BOUYER, PROF
principal investigator · University Hospital, Bordeaux

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion